Transforming Growth Factor-β in Human Diabetic Nephropathy
Robyn G. Langham(The University of Melbourne), Richard E. Gilbert(St. Michael's Hospital)
Cited by 54
Related Papers
Inhibition of Protein Kinase C–β by Ruboxistaurin Preserves Cardiac Function and Reduces Extracellular Matrix Production in Diabetic Cardiomyopathy
|Circulation Heart Failure|2009|116
Sodium-Glucose Linked Cotransporter-2 Inhibition Does Not Attenuate Disease Progression in the Rat Remnant Kidney Model of Chronic Kidney Disease
|PLoS ONE|2016|79
Load-independent effects of empagliflozin contribute to improved cardiac function in experimental heart failure with reduced ejection fraction
|Cardiovascular Diabetology|2020|70